Leukemia, Hairy Cell: Clinical Trials

23 trials for Leukemia, Hairy Cell, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 2 unknown, 1 recruiting, 1 terminated. 23 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 323Completed 19, Unknown 2, Recruiting 1, Terminated 1
Phase 21Recruiting 1

Follow Leukemia, Hairy Cell: new trials by email Literature Review of Leukemia, Hairy Cell trials Research Report on Leukemia, Hairy Cell

Trials (filtered) newest first · largest first

All 23 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes
HCL, verapamil 120mg tablet, non-HCL - Type1 Diabetes
Phase 3CompletedJaeb Center for Health Research1132020-07-092024-11-27
Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia
Moxetumomab pasudotox, IV Bag Protectant for Moxetumomab pasudotox - Leukemia, Hairy Cell
Phase 3CompletedMedImmune LLC802013-04-292020-04-08
Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain
ketamine hydrochloride, pharmacogenomic studies, questionnaire administration - Cancer
Phase 3UnknownUniversity of Glasgow2142009-04-012011-05-13
American Ginseng in Treating Patients With Fatigue Caused by Cancer
American ginseng, placebo - Chronic Myeloproliferative Disorders, Fatigue
Phase 3CompletedAlliance for Clinical Trials in Oncology3642008-10-012017-02-09
Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications
internet-based intervention, questionnaire administration, psychosocial assessment and care - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 3CompletedFred Hutchinson Cancer Research Center/University of Washington Cancer Consortium13372008-08-012012-03-07
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial
educational intervention - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders
Phase 3CompletedCase Comprehensive Cancer Center5832008-04-012020-07-27
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Fentanyl sublingual spray, Placebo - Cancer
Phase 3CompletedINSYS Therapeutics Inc1302007-10-012014-03-05
Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant
moxifloxacin hydrochloride, Placebo - Breast Cancer, Chronic Myeloproliferative Disorders
Phase 3TerminatedOHSU Knight Cancer Institute2402006-05-012017-05-09
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer
darbepoetin alfa, ferrous sulfate, sodium ferric gluconate complex in sucrose - Anemia, Leukemia
Phase 3CompletedMayo Clinic5022006-01-012011-05-17
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
educational intervention, Titrated pain management, questionnaire administration - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders
Phase 3CompletedVanderbilt-Ingram Cancer Center982005-05-012012-09-06
Therapy Optimisation for the Treatment of Hairy Cell Leukemia
Cladribine s.c. injection, HCL treatment - Hairy Cell Leukemia
Phase 2 / Phase 3RecruitingUniversity of Giessen2102004-05-012024-08-22
Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation
acyclovir, acyclovir sodium, valacyclovir - Cancer
Phase 3CompletedFred Hutchinson Cancer Center2002-04-012010-09-21
Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia
cefepime hydrochloride, levofloxacin - Fever, Sweats, and Hot Flashes, Infection
Phase 3UnknownJonsson Comprehensive Cancer Center2001-09-012013-12-19
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment
ondansetron, placebo - Chronic Myeloproliferative Disorders, Leukemia
Phase 3CompletedAlliance for Clinical Trials in Oncology1002000-10-012016-07-06
Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
caspofungin acetate, liposomal amphotericin B - Cancer
Phase 3CompletedMemorial Sloan Kettering Cancer Center2000-08-012013-01-18
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
Fragmin, placebo - Cervical Cancer, Chronic Myeloproliferative Disorders
Phase 3CompletedJonsson Comprehensive Cancer Center2000-04-012020-08-03
St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer
St. John's wort - Chronic Myeloproliferative Disorders, Fatigue
Phase 3CompletedMemorial Sloan Kettering Cancer Center1999-12-012013-01-18
Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation
captopril, cyclophosphamide, autologous bone marrow transplantation - Cancer
Phase 3CompletedNorthwestern University351999-10-012012-06-06
Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients
liposomal amphotericin B - Cancer
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC1151999-06-012012-09-24
Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation
palivizumab, ribavirin - Cancer
Phase 3CompletedFred Hutchinson Cancer Center1999-02-012010-04-02

Showing 20 of 23. Sign in to see all of them.

Narrower conditions

Burkitt Lymphoma (20)  ·  Hodgkin Disease (20)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (20)  ·  Lymphoma, B-Cell, Marginal Zone (20)  ·  Lymphoma, Follicular (20)  ·  Lymphoma, Large B-Cell, Diffuse (20)  ·  Lymphoma, Large-Cell, Immunoblastic (20)  ·  Lymphoma, Mantle-Cell (20)  ·  Lymphoma, Non-Hodgkin (20)  ·  Lymphoma, T-Cell, Cutaneous (20)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (20)  ·  Blast Crisis (19)  ·  Leukemia, Myeloid, Accelerated Phase (19)  ·  Leukemia, Myeloid, Acute (19)

Broader conditions

Hematologic Diseases (23)  ·  Hemic and Lymphatic Diseases (23)  ·  Immune System Diseases (23)  ·  Immunoproliferative Disorders (23)  ·  Lymphatic Diseases (23)  ·  Neoplasms by Histologic Type (23)  ·  Chronic Disease (20)  ·  DNA Virus Infections (20)  ·  Disease Attributes (20)  ·  Epstein-Barr Virus Infections (20)  ·  Herpesviridae Infections (20)  ·  Leukemia, B-Cell (20)  ·  Leukemia, Lymphoid (20)  ·  Leukemia, Myeloid (20)  ·  Lymphoma, B-Cell (20)

Interventions

Early Intervention, Educational (2)  ·  liposomal amphotericin B (2)  ·  Acyclovir (1)  ·  Asian ginseng (1)  ·  Captopril (1)  ·  Caspofungin (1)  ·  Cefepime (1)  ·  Counseling (1)  ·  Cyclophosphamide (1)  ·  Dalteparin (1)  ·  Darbepoetin alfa (1)  ·  Dextromethorphan (1)  ·  Fentanyl (1)  ·  Fluconazole (1)  ·  Hypericum extract LI 160 (1)

Sponsors

Fred Hutchinson Cancer Center (3)  ·  Alliance for Clinical Trials in Oncology (2)  ·  European Organisation for Research and Treatment of Cancer - EORTC (2)  ·  Jonsson Comprehensive Cancer Center (2)  ·  Memorial Sloan Kettering Cancer Center (2)  ·  Case Comprehensive Cancer Center (1)  ·  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium (1)  ·  INSYS Therapeutics Inc (1)  ·  Jaeb Center for Health Research (1)  ·  Mayo Clinic (1)  ·  MedImmune LLC (1)  ·  NCIC Clinical Trials Group (1)  ·  Northwestern University (1)  ·  OHSU Knight Cancer Institute (1)  ·  University of Giessen (1)

Countries

United States (19)  ·  Germany (4)  ·  Belgium (3)  ·  Canada (3)  ·  Czechia (3)  ·  France (3)  ·  Israel (3)  ·  United Kingdom (3)  ·  Greece (2)  ·  Italy (2)  ·  Slovakia (2)  ·  Spain (2)  ·  Turkey (Türkiye) (2)  ·  Finland (1)  ·  Hungary (1)

Top investigators

Antoinette Moran, MD (1)  ·  Barry J.A. Laird, MD (1)  ·  Charles L. Loprinzi, MD (1)  ·  David J. Straus, MD (1)  ·  Debra Barton, RN, PhD, AOCN, FAAN (1)  ·  Eduardo Bruera, MD (1)  ·  Garrett Nichols, MD, MSC (1)  ·  Gregory Forlenza, MD (1)  ·  John A. Glaspy, MD, MPH (1)  ·  Joseph Bubalo, PharmD, BCPS, BCOP (1)  ·  Karen Syrjala (1)  ·  Kent Sepkowitz, MD (1)  ·  Kieren A. Marr, MD (1)  ·  Larry Dillaha, MD (1)  ·  Leo I. Gordon, MD (1)

Results publications

PMID 15459300, PMID 17397698, PMID 22480131, PMID 26700120, PMID 26700123, PMID 27020837, PMID 31298972, PMID 32628342, PMID 33420905, PMID 33627164, PMID 36282798, PMID 36826834, PMID 36826844, PMID 36999619, PMID 38860154

NIH funding

P30CA015083 (1), P30CA068485 (1), P30CA069533 (1), R01CA112631 (1), R01CA127655 (1)